Category: Diversified Tech

Consumer Goods, Diversified Tech, Finance

Kimberly-Clark Withstands Pressure, Posts Adequate Earnings Results in Quarter

With a portfolio of leading brands and an expansive global distribution network, Kimberly-Clark continues to withstand the challenges resulting from intense competitive activity and lackluster macro conditions. Management raised the lower end of its full-year adjusted earnings per share expectations to $5.65-$5.75 (from $5.60 and compared with our forecast of $5.71), partly reflecting a lower tax rate and share count. Our $93 fair value estimate … Continue reading Kimberly-Clark Withstands Pressure, Posts Adequate Earnings Results in Quarter

John BellichLeave a comment
Diversified Tech, Finance

Anixter Posts Disappointing Q3 Revenue

Anixter reported third-quarter revenue and net income that imply 2013 results will be below street expectations, primarily because of emerging-market customer (13% of quarterly sales) project delays into the fourth quarter and early 2014.  Additionally, heavy-truck manufacturing customers have delayed their anticipated business improvement into 2014, relative to prior expectations for strong sales in late 2013. We have modestly reduced our 2013 operating income and … Continue reading Anixter Posts Disappointing Q3 Revenue

John MeadyLeave a comment
Diversified Tech, Finance, Financial, Mergers & Acquisitions, Services Sector, Software, Tech IPO

KPN Meets Street Expectations in Third Quarter

KPN reported third-quarter results that were generally in line with our expectations, and we are maintaining our fair value estimate and moat rating for now. While the firm has chosen to classify E-Plus, the German operation it agreed to sell to Telefonica, as a discontinued operation, we are including the division as we think there is still a significant chance that European regulators will not … Continue reading KPN Meets Street Expectations in Third Quarter

Jason KnoxLeave a comment
Diversified Tech, Finance

Roche’s Top-line Results on Track to Meet Guidance

Roche reported top-line results for the third quarter that put it on track to meet our expectations for the full year. Roche’s oncology drug portfolio and diagnostics segment form the basis of its personalized medicine strategy, feeding into the firm’s strong intangible assets and wide economic moat. At constant currencies, Roche’s sales were up 8% in the third quarter, with 9% pharmaceutical growth and 7% … Continue reading Roche’s Top-line Results on Track to Meet Guidance

Ryan HoltzLeave a comment
Analysis, BioTech, Commodities, Diversified Tech, Finance, Global Equity, Mergers & Acquisitions, Semiconductors, Services Sector, Software, software, Tech IPO

Still-Weak European Paper Demand Weighed on UPM’s 1Q Results

Despite relatively steady performance from the energy and pulp segments, UPM’s quarterly EBITDA contracted 20% year over year; EBITDA from the paper business was nearly halved over the same period. As the world’s largest producer of graphic paper, UPM remains highly dependent on its paper business, where volume continues to decline–European magazine papers fell 6%, newsprint fell 3%, and fine papers fell 6%–and present significant … Continue reading Still-Weak European Paper Demand Weighed on UPM’s 1Q Results

John MeadyLeave a comment
Analysis, BioTech, Diversified Tech, Finance, Financial

Idexx Labs’ Salesforce Integration Highlights Solid Quarter

Idexx Laboratories posted solid third-quarter results that fell squarely within expectations. The firm has made progress in its remodeling of its salesforce structure to a new configuration that makes it easier for customers to interact with a single point of access at Idexx, and we expect this reorganization should manifest itself in further growth over the next few quarters. We are keeping our narrow-moat rating … Continue reading Idexx Labs’ Salesforce Integration Highlights Solid Quarter

Adam KeintzelLeave a comment